重新利用安二B及其脂质体配方用于治疗人类mpox
Daniela Peruzzu1, Katia Fecchi1, Giulietta Venturi2
1Center for Gender-Specific Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
International journal of molecular sciences
|May 27, 2023
概括
抗真菌药物Amphotericin B (AmphB) 可能通过破坏宿主细胞脂质来抑制mpox病毒 (MPXV) 感染. 这为mopox治疗提供了潜在的新疗法策略.
科学领域:
- 病毒学 病毒学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 由mpox病毒 (mpxv) 引起的mpox (麻疹) 是一种动物传播疾病,最近在多个国家爆发,引起全球关注.
- 2022年的疫情显示,通过密切的性接触增加了传播,特别是在有多个性伴侣的男性中.
- 目前针对mopox的治疗方法有限,现有的基于疫苗病毒 (VACV) 的疫苗对这种疫情的疗效尚未得到充分证实.
研究的目的:
- 探索阿姆福特里辛B (AmphB) 作为针对mpox病毒 (MPXV) 的治疗剂的潜力.
- 研究AmphB可能抑制MPXV感染的机制,重点关注宿主细胞脂质.
主要方法:
- 这项研究讨论了Amphotericin B (AmphB) 在通过隔离胆固醇来破坏宿主细胞脂质的已知特性.
- 它假设AmphB对脂质的破坏可以抑制MPXV进入宿主细胞.
主要成果:
- 之前已经证明,安福特素B (AmphB) 通过破坏宿主细胞脂质来抑制各种感染.
- 该研究假设AmphB可以通过改变脂质架构和病毒进入受体/共受体的分布来抑制MPXV的进入.
结论:
- 氨基氨酸B (AmphB) 通过向宿主细胞脂质,为mpox (麻疹) 提供了一个潜在的治疗策略.
- 需要进一步的研究来验证AmphB对MPXV感染的疗效,在正在进行的mopox疫情的背景下.
相关概念视频
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...